22157.jpg
Worldwide Mammography Devices Industry to 2026 - Key Drivers and Challenges
January 28, 2022 06:03 ET | Research and Markets
Dublin, Jan. 28, 2022 (GLOBE NEWSWIRE) -- The "Global Mammography Devices Market, By Product Type (Full-field Digital Mammography, Film-screen Mammogram, Breast Tomosynthesis), By Technology...
Breast Cancer Awaren
Breast Cancer Awareness Month
September 09, 2021 17:58 ET | Solis Mammography
Dallas, TX, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Breast cancer does not discriminate. No one expects to be diagnosed with this disease, particularly women under the age of 40. According to the...
22157.jpg
Insights on the Mammography Systems Global Market to 2029 - Booming Healthcare Industry is Driving Growth
June 16, 2021 07:48 ET | Research and Markets
Dublin, June 16, 2021 (GLOBE NEWSWIRE) -- The "Mammography Systems Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
22157.jpg
Insights on the Breast Imaging Global Market to 2025 - Key Drivers and Restraints
September 03, 2020 07:59 ET | Research and Markets
Dublin, Sept. 03, 2020 (GLOBE NEWSWIRE) -- The "Breast Imaging Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering. The breast imaging market is...
CorporateSeal- Gold Small size.jpg
Women’s Choice Award® Announces 2017 America’s Best Breast Centers
October 10, 2017 09:45 ET | Women's Choice Award
FT. LAUDERDALE, Fla., Oct. 10, 2017 (GLOBE NEWSWIRE) -- The Women’s Choice Award®, America’s trusted referral source for the best in healthcare, has announced its 2017 America’s Best Breast Centers...
BREVAGen reclassified 64 percent of above average Gail risk subjects
CONTEMPORARY OBSTETRICS AND GYNECOLOGY OF DAYTON ANNOUNCES THE AVAILABILITY OF STATE-OF-THE-ART BREAST CANCER RISK ASSESSMENT TEST
September 30, 2013 10:34 ET | Genetic Technologies Group
DAYTON, Ohio, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Contemporary Obstetrics & Gynecology, part of the Providence Medical Group, today announced the availability of the BREVAGen™ predictive risk...
BREVAGen Logo_edit
OB/GYN ASSOCIATES IN LEWISBURG, PA ANNOUNCES THE AVAILABILITY OF STATE-OF-THE-ART BREAST CANCER RISK ASSESSMENT TEST
August 26, 2013 13:06 ET | Genetic Technologies Group
SUNBURY, PA., Aug. 26, 2013 (GLOBE NEWSWIRE) -- Russell Stankiewicz, MD, FACOG, CCD, NMCP, is pleased to announce that OB/GYN Associates of Lewisburg, P.C. in Lewisburg, PA is now offering the...
Atossa Genetics, Inc. Announces Filing of S-1 Registration Statement
October 01, 2010 09:30 ET | Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - October 1, 2010) - Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk...
Atossa Genetics, Inc. Appoints Robert L. Kelly as President
May 25, 2010 09:00 ET | Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - May 25, 2010) -  Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of leading edge and unique cellular and molecular...
Atossa Genetics, Inc. Appoints Edward Sauter, M.D., Ph.D., to Its Scientific Advisory Board
February 25, 2010 11:00 ET | Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - February 25, 2010) -  Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic...